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ABSTRACT 
 
Background: Endoleak has been reported as a major complication among patients who have 
undergone endovascular repair of their abdominal aortic aneurysm (AAA).  Several studies made 
efforts towards identifying the risk factors for the development of endoleak through various studies 
and data analyses.  Among all the findings, one result--smoking significantly lowers a patient’s risk 
for an endoleak--has been confirmed multiple times.  But such a result appears to be contradictory 
to what researchers have anticipated; yet the contradictory has not been closely studied. 
Methods: Data on endoleaks from the Department of Veterans’ Affairs Open Versus Endovascular 
Repair (OVER) randomized controlled trial was used, and 419 male subjects with smoking histories 
were included in the analysis.  A series of logistic regression models and propensity score models 
was constructed with the baseline and follow-up variables.  Multiple imputation techniques were 
utilized to minimize the impact of missing data and to improve analytical robustness.  In addition, a 
simulation study was also undertaken to better evaluate the models above. 
Results: About half (5/12) of the logistic regression models supported the significant effect on endoleak 
of smoking in the model, and a smaller proportion (3/18) of propensity score models indicated that 
smoking was a significant factor for endoleak.  Missing values had an important impact on the results.  
Although smoking’s effects were not significant for little more than half of the models, odds ratio of 
developing endoleak for current smokers were always less than 1 compared with non-current smokers, 
which may be clinically meaningful.  Results from simulation studies suggest that clinical trials with 
larger sample size might be necessary to reach a definitive conclusion on this topic. 
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INTRODUCTION 
Open heart surgery used to be the routine treatment for patients with Abdominal Aortic Aneurysm (AAA) 
more than twenty years ago
1
.  Ever since the introduction of minimally invasive endovascular stent 
grafts in 1986
2
, endovascular aneurysm repair (EVAR) had become a popular alternative treatment for 
AAA patients, partly because of the increasing recognition of EVAR’s superior advantage of decreasing 
perioperative mortality
1,3-5
.  In spite of the benefits, endovascular repair had drawbacks.  Endoleak, a 
symptom of continuous blood flow between graft and aneurysm sac, had been discovered as a major 
complication among patients who had received endovascular repair
6
.  Endoleak was also regarded as a 
signal of surgery failure in several studies
7, 8
.  Although the absence of an endoleak does not necessarily 
mean that the patient is free from risk (Gilling-Smith and his colleagues found that ruptures could happen 
to patients with no endoleak)
9
, there is no doubt that the appearance of an endoleak implies unsuccessful 
exclusion of the aneurysm.  It had been found that certain types of endoleak (for example Type I 
endoleak) were more dangerous than some other types, since these types of endoleak were  closely 
related with a higher risk of aneurysm sac enlargement, and the aneurysm sac enlargement may 
subsequently cause aneurysm rupture
10, 11
.  Consequently, patients with endoleak may have to receive 
secondary interventions to fix the related problems, and the cost of treatment increases at the same time
12
. 
 
Experience from several studies had showed that 20% - 35% of the patients undergoing endovascular 
aneurysm reparation developed endoleaks after interventions
12-15
.  Because of the high frequency and 
potential risks of endoleak, researchers had spent efforts to investigated  the risk factors for the 
development of endoleak 
11, 15-18
.  Knowledge about these risk factors can potentially assist health 
practitioners to pre-select AAA patients who may benefit from endovascular aneurysm repairation and to 
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lower the possibility of endoleak.  Studies about endoleak suggested that age, aneurysm size, smoking 
status, etc. were related with the incidence of endoleak.  In analyzing data from these risk factors, 
smokers had been identified to be at lower risk of endoleak, was is the most unexpected and least 
understood
11, 15-18
.   
 
As part of the EUROSTAR study, Marrewijk et al., Mohan et al., and Buth et al. collected pre- and 
post-operative data of AAA patients who had received endovascular repairation from 110 medical centers 
all over Europe
11,15,17
.  They reported that the non-endoleak group had lower proportion of smokers 
compared to the endoleak group.  Mohan et al. had completed the most comprehensive study among the 
three studies on the topic of smoking and endoleak
15
, and through a series of logistic regression models, 
Mohan et al. found that current smokers smoking more than 20 cigarettes per day had the lowest risk of 
endoleak compared with current smokers smoking less than 20 cigarettes, and ex-smokers.  Such results 
appeared to confirm  the hypothesis that smoking provided some protection against the development of 
endoleak.  The results above demonstrating the relation between smoking and endoleak were not 
coincidental.  Zarins et al. published similar results from their AneuRx multicenter clinical trial in 1999 
and also found higher proportions of smokers in patients without endoleak than in those with endoleak
16
. 
 
Although the results about the relation between smoking and endoleak had accumulated through different 
studies, a close scrutiny over the analysis demonstrated that results were generated through the application of 
student t-tests, chi-square tests, and/or multivariate regression models
11,15-17
.  Because smoking would 
obviously raise some ethical concerns in the context of a randomized trial, data on such topics were mostly 
observational.  Observational data could have certain disadvantages, such as unbalanced baseline 
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characteristics between two experiment arms
19
.  However, it didn’t mean that simple methodology was not 
good enough.  On the contrary, when both simple and complex methods were feasible in solving problems, 
simple methods should always be the first consideration.  We suggested that researchers should be more 
cautious when conducting analysis based on observational data.  In this context, more comprehensive analysis 
needs to be done to better understand the relationship of quitting smoke and developing endoleak.   
 
In this paper, I used both logistic regression model and propensity score model to investigate the effect of 
quitting smoke on the incidence of an endoleak in male veterans.  The analysis was based on the data from 
Open versus Endovascular Repair (OVER) trial, which was conducted by Veterans Healthcare System from 
2002 to 2011.  More description about dataset can be found in the methods section.  In addition to analyzing 
the real experiment data from OVER trial, I also used imputation methods and a simulation study to minimize 
the influence of missing data and maximize our understanding of parameter estimates in both models. 
 
METHOD 
Data source 
OVER trial was a randomized, multicenter clinical trial conducted by Veterans Affairs Cooperative Study 
Group (VACSPCC) from October 15, 2002 to October 15, 2011.  The main goal was to provide 
information on short-term and long-term comparison between open repair and endovascular repair of 
AAA.  The OVER trial enrolled 881 veterans who were 49-year or order  and who were eligible for 
both open and endovascular repair of their AAA.  Of the 891 study participants, a total of 444 were 
randomized to endovascular group and 437 were randomized to open group.  Not all subjects 
successfully received the treatment they were assigned to (31, 3.5% of the subjects failed to accept the 
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assigned treatment, including 18 subjects randomized to EVAR group and 13 subjects randomized to 
Open group).  
 
Baseline measurements were collected for all subjects including age, height, weight, left ABI, right ABI, 
smoking status, and family history of abdominal aortic aneurysm.  After repairation, follow-up visits were 
scheduled at 1 month, 3 months and 6 months in the first year, and once every year from the second year on, . 
The follow-up visits for patients who had received endovascular repairs included computed tomography and 
plain radiography of the abdomen.  Endoleak status was ascertained at the same time. More details about 
OVER trial could be found in the published short-term and long-term reports
3,4
. 
 
Although the OVER trial collected data of the subjects in both open repair and endovascular repair groups, 
I only used the data of patients who received endovascular repair, because only those who received 
endovascular repair had the risk of developing endoleak.  The original endovascular population 
included 3 female subjects (0.68%) and they were eliminated from the analysis to keep the homogeneity 
of study group.  In addition, since our study topic was about quitting smoke, subjects who never smoked 
were also excluded.  The final data set included 419 endovascular patients.  Of all subjects, a total of 
252 were current non-smokers but had smoking history which considered as treatment group, a total of 167 
were current smokers which considered as control group.  In this study, “treatment” stood for quitting 
smoke. 
 
Data analysis 
Preliminary analysis – Population characteristics (at time of randomization) were tabulated by smoking 
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status and endoleak incidence respectively.  P values based on two sample t test (for continuous variables) 
or chi-square test (for binary variables) were also generated for each baseline variables.  For unbalanced 
variables, histograms of variables against smoking status or endoleak status were generated to better 
understand their distributions. 
 
Propensity score methods – As discussed in introduction section, data from an observational study may 
have  unbalanced characteristics between treatment group and control group.  And these differences may 
lead to biased estimation for treatment effects.  Propensity score for each subject was usually calculated in 
this context to balance the covariates differences between treatment group and control group, in order to 
reduce the bias.  The methods described by Rosenbaum and Robin
19
 were used to generate propensity score 
for the purposes of this study. 
Suppose subject i (i=1, …, N) were randomized to treatment (Zi=1) and control (Zi=0).  Given a vector 
of observed covariates, propensity score stood for the conditional probability of assignment to treatment 
(Zi=1) for this subject, and it was denoted by 
e(𝑥𝑖 -) = 𝑝𝑟(𝑧𝑖 = 1|𝑥𝑖) 
where it was assumed that 
pr(𝑧1, 𝑧2, … , 𝑧𝑛|𝑥1, 𝑥2, … , 𝑥𝑛) = -∏𝑒(𝑥𝑖)
𝑧𝑖{1 − 𝑒(𝑥𝑖)}
1−𝑧𝑖
𝑁
𝑖
 
Rosenbausm and Rubin concluded that propensity score was the coarsest balancing score of observed 
covariates x
19
.  Balancing score b(x) was defined as a function of x such that given b(x) the conditional 
distributions of x for subject in treatment group (Zi=1) and the subject in control group (Zi=0) were the same; 
in other words, given treated and controlled subjects had a same propensity score, the treatment assignment 
was strongly ignorable and the treatment effect could be calculated by the differences between the responses 
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of treated and controlled groups.  Balancing score was a bridge for non-randomized experiments to imitate 
randomized experiments.  A critical difference between randomized experiments and non-randomized 
experiment s was whether the two groups were comparable.  Specifically, randomized experiments had 
two similar treatment groups (in terms of baseline variables, and except for the treatment modality), thus 
they may be directly compared; while non-randomized experiments may have systematically different 
treatment groups and direct comparison may not be meaningful.  Through balancing the score, the subjects 
in two groups could be matched or stratified, so that t h e  meaningful treatment effect estimation could be 
achieved. 
 
Rosenbaum and Rubin also suggested that propensity score could be modeled using logistic regression or 
discriminant score 
19
.  Discriminant score utilized the assumption that observed covariates have 
multivariate normal distribution, while logistic regression models had no prior distribution assumption for 
covariates.  One requirement for both calculation methods was that the data should not contain any 
missing data.  Logistic regression was used to estimate the propensity scores.  A detailed primary 
analysis of the characteristics of estimated propensity score can be found in the Results Section(page 13).  
After propensity scores were generated, three methods – matching, stratification, and covariate adjustment 
– were used in the following analysis. 
 
Matching by propensity score: Although it was straight-forward that the subjects with similar propensity 
score in treatment group and control group were matched , several techniques such as greedy matching with 
caliper distance, optimal matching, exact matching, complete matching, and mahalanobis matching, were 
usually used and these methods could either use 1:1 matching or 1:n matching.  Austin had conducted 
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comprehensive research to compare most of these matching techniques (matching on the logit of the 
propensity score using calipers of width either 0.2 or 0.6 of the standard deviation of the logit of the 
propensity score; matching on the propensity score using calipers of 0.005, 0.01, 0.02, 0.03, and 0.1; and 5 to 
1 digit matching on the propensity score)
20,21
.  Austin concluded that matching using caliper of width of 0.2 
of the standard deviation of the logit of the propensity score and using caliper of width of 0.02 and 0.03 were 
likely to have better performance for estimating treatment effects compared with other techniques.  
Matching using caliper of width of 0.2 of the standard deviation of the logit of the propensity score was also 
used in the current analysis.  In the endoleak dataset, the sample size of the treatment group was similar to 
the sample size of the control group, so a greedy 1:1 matching with (a) 0.1 of the standard deviation of the 
logit of the propensity score; (b) 0.2 of the standard deviation of the logit of the propensity score; (c) 0.25 of 
the standard deviation of the logit of the propensity score, and (d) mahalanobis matching. 
 
Stratification, also known as subclassification, was the second major method of using propensity scores to 
adjust unbalanced characteristics between the treated and the control groups in observational studies.  
Stratification was proposed by Cochran in 1965 and the original method was only used to adjust for 
confounding variable(s)
22
.  The main problem of the original method was that with the number of 
confounding variables increasing, the number of strata or subclasses increased exponentially.  Stratifying 
by propensity score was a useful way to solve such problem.  Moreover, propensity score methods can 
generate more meaningful strata by considering all unbalanced binary and continuous variables when 
modeling.  A question that usually arose when stratifying by propensity score was the number of strata used.  
Researchers found that stratification with creating five classes was sufficient to eliminate 90 percent of the 
bias due to the unbalanced covariates in treatment and control groups
22
, and such results was supported 
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theoretically by Rosenbaum and Rubin’s article
19
.  As a result, propensity score-based stratification with 
five strata was used in the analysis in this paper.  Detailed results and diagnostics can be found in the Result 
Section (page 17). 
 
Covariate adjustment was a method using propensity score directly as a covariate in modeling treatment 
effects as responses.  Other unbalanced variables after adjusting with propensity score would also be 
included in the model.  The difference between using propensity score as covariate in the regression 
model and using all variables in the regression model as covariates might be a question.  Rosenbaum 
and Rubin commented that “the point estimate of the treatment effect obtained from an analysis of 
covariance adjustment for multivariate x, in fact, equaled to the estimation obtained from univariate 
covariate adjustment for the sample linear discriminant based on x, whenever the same sample 
covariance matrix was used for both the covariance adjustment and the discriminant analysis”
19
. 
Therefore, these two methods should generate similar results.  However, as suggested in the article by 
RB D’Agostino. Jr., propensity score had the “dim-decrease” advantage
23
.  When generating 
propensity score, all related variables, including interaction terms and high order terms, can be included, 
since the goal of logistic model at that stage was for prediction and including many variables did not 
harm the results, rather would improve the accuracy.  On the contrary, parsimonious models were 
usually preferred when regression model with all variables was used for easier diagnostics and 
interpretation.  The Endoleak dataset used for analysis had more than 20 baseline variables, and thus in 
this case propensity score may provide more accurate estimation for treatment effects than regression 
model with all covariates. 
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Multiple Imputation - Missing values had always been a challenge in data analysis.  Rubin’s multiple 
imputation procedure filled in each missing position with a series of plausible values which may probably 
represent the true values
25
.  This approach provided a helpful strategy to address the missing value issue.  
In practice, several techniques had been proposed and could be easily implemented by software, including 
parametric regression method, propensity score method, and Markov chain Monte Carlo (MCMC) method
24
.  
For different missing patterns, different imputation techniques could be used.  For instance, parametric 
regression method and propensity score method fitted monotone missing data patterns, and MCMC method 
fitted any arbitrary missing pattern.  In the endoleak dataset, missing data pattern was not monotone, thus 
MCMC method had been used for the imputation process. 
 
Simulation - To better understand the variability of the parameter estimation and to further compare the 
results of logistic regression and propensity score, I simulated 100 data sets on the basis of MCMC-imputed 
endoleak data.  The first MCMC-imputed endoleak dataset was generated after 200 burn-in 
estimation-maximization algorithm lops.  At that time, the algorithm had already converged and the 
Markov chain had reached the state of stable.  The rest of the imputed endoleak datasets were generated 
with 100 iterations between one and the successive one. 
 
Each observation in the simulated data set was generated on the basis of imputed endoleak data set to make 
the simulated data similar to endoleak data.  The simulation processes of variables were different between 
continuous variables and binary variables.  For a continuous variable X, denote that the standard deviation 
of X by SDx and the simulated data point of X by Xn.  Xn was generated by 
𝑋𝑛 = 𝑋 + 𝑟𝑁(0, (0.1 × 𝑆𝐷𝑋)
2) 
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rN(0,-(0.1 × 𝑆𝐷𝑋)
2) was the random number from normal distribution with mean 0 and variance (0.1 ×
𝑆𝐷𝑋)
2.  For a binary variable Y, denote that the simulated data point of Y by Yn.  Yn was generated by 
𝑌𝑛 = 𝐼(𝑟𝑈(0,1) < 0.9) × 𝑌 + 𝐼(𝑟𝑈(0,1) ≥ 0.9) × (1 − 𝑌) 
𝑟𝑈(0,1) was the random number of uniform(0,1) distribution.  
 
The simulated data was analyzed by logistic regression and propensity score as above.  
 
RESULTS 
Preliminary analysis 
After eliminating female subjects and male subjects who had never smoked, the endoleak dataset included 
419 subjects in total.  Table1 contains the characteristics of all patients at baseline by smoking status and 
primary outcomes.  From Table 1, the first and the most unbalanced variable detected was age.  The 
average age of current smokers was 67.1, while the average age of current non-smokers was 70.8.  Current 
non-smokers were significantly older than current smokers (P value from two sample t-test was less than 
0.0001).  Age was also significantly related with endoleak occurrence (P value from two sample t-test 
equaled 0.032).  The average age of the subjects who had endoleaks was 70.5, which was larger than the 
average age of those did not have endoleaks (68.8).  Figure 1 presents the histogram of age versus smoking 
status and versus endoleak occurrence.  The figure confirmed that smokers were, on average, younger than 
non-smokers; and the subjects with endoleaks were, on average, older than subjects without endoleaks. 
 
In addition to age, weight was significantly related with smoking status or endoleak occurrence (although 
diabetes history and anticoagulants medicine taking history had borderline P value against endoleak, 0.052 
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for both variables) among all other baseline measurements.  The average weight of current non-smokers 
was 92.6kg which was greater than the average weight of current smokers, 88.0kg.  No significant 
relation was found between weight and endoleak.  Figure 2 shows the histogram of weight versus 
smoking status and versus endoleak occurrence. 
 
Table 1: Characteristics of the patients at the time of randomization 
Variables N 
Smoking Status 
P* 
Outcome 
P* 
Current 
Smokers 
(N=167) 
Current 
Non-smokers 
(N=252) 
Endoleak 
(N=125) 
No-endoleak 
(N=294) 
Continuous variables – mean (sd) 
Age-yr 419 67.1(6.8) 70.8(7.9) <.0001 70.5(8.2) 68.8(7.4) 0.032 
Height-cm 419 177.8(7.3) 177.5(7.7) 0.74 177.7(7.4) 177.6(7.6) 0.90 
Weight-kg 419 88.0(17.8) 92.6(16.3) 0.0063 90.2(16.6) 91.0(17.3) 0.67 
Left ABI 383 1.0(0.2) 1.0(0.6) 0.61 1.1(0.8) 1.0(0.2) 0.20 
Right ABI 382 1.0(0.2) 1.0(0.6) 0.75 1.1(0.9) 1.0(0.2) 0.22 
Binary variables – no. (%) 
Currently smokes  419 - - - 39(31.2) 128(43.54) 0.018 
Family history of abdominal 
aortic aneurysm 
419 29(17.4) 36(14.3) 0.39 23(18.4) 42(14.3) 0.29 
Diabetes 419 32(19.2) 57(22.6) 0.40 34(27.2) 55(18.7) 0.052 
High cholesterol 419 121(72.5) 183(72.6) 0.97 93(74.4) 211(71.8) 0.58 
Thrombosis 419 11(6.6) 11(4.4) 0.32 5(4.0) 17(5.78) 0.45 
Hypertension 419 128(76.7) 201(79.8) 0.45 101(80.8) 228(77.6) 0.46 
Emphysema 419 47(28.1) 72(28.6) 0.92 32(25.6) 87(29.6) 0.41 
Coagulopathy 419 2(1.2) 3(1.2) 0.99 2(1.6) 3(1.0) 0.62 
Stroke 419 30(18.0) 32(12.7) 0.14 18(14.4) 44(15.0) 0.88 
Cardiac disease 419 1(0.6) 1(0.4) 0.44 72(57.6) 142(48.3) 0.16 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: Beta-blockers 419 111(66.5) 163(64.7) 0.71 88(70.4) 186(63.3) 0.16 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: Aspirin 419 89(53.3) 142(56.4) 0.54 74(59.2) 157(53.4) 0.27 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: ACE 
inhibitors 
419 76(45.5) 107(42.5) 0.54 56(44.8) 127(43.2) 0.76 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: 
Anticoagulants 
419 15(9.0) 27(10.7) 0.56 18(14.4) 24(8.2) 0.052 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: Other platelet 
inhibitors 
337 8(6.3) 16(7.7) 0.63 11(10.5) 13(5.6) 0.11 
* P value of two sample t-test (for continuous variables) or chi-square test (for binary variables). 
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¶ Medications last 6 months prior to randomization. 
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Age by Smoking Status Age by Endoleak 
Figure 1: Histogram of age by smoking status (left) and by endoleak occurrence (right).  X-axis stands for age, 
ranging from 50 to 90.  Y-axis stands for incidence percent.  The two plots on the upper side are age for current 
non-smokers (left) and for subjects with no endoleaks (right).  The two plots on the lower side are age for 
current smokers (left) and for subjects with endoleaks (right).  For age and smoking status, P value from two 
sample t-test is less than 0.0001.  For age and endoleak, P value from two sample t-test equals 0.032.  
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Weight by Smoking Status Weight by Endoleak 
Figure 2: Histogram of weight by smoking status (left) and by endoleak occurrence (right).  X-axis stands for 
age, ranging from 52(52.5) to 187(187.5).  Y-axis stands for incidence percent.  The two plots on the upper 
side are weight for current non-smokers (left) and for subjects with no endoleaks (right).  The two plots on the 
lower side are weight for current smokers (left) and for subjects with endoleaks (right).  For weight and 
smoking status, P value from two sample t-test is less than 0.0063.  For age and endoleak, P value from two 
sample t-test equals 0.67.  
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Another issue in the table 1 was the missing values for three variables – left ABI 36(8.6%), right ABI 
37(8.8%), and other platelet inhibitor use history 82(19.6%).  To better understand the missing pattern, 
baseline characteristics were compared between subjects who had missing values and subject who were 
observed.  The results were demonstrated in Table 2.  And all subjects who missed left ABI measurement 
also missed right ABI.  But only one subject with the right ABI value missing, had the variable of left ABI 
not missing.  Therefore, left ABI miss/not-miss in the analysis (left column) was used to represent results 
for left ABI and right ABI.  From Table 2, it was discovered that subjects who had ABI values missing 
were significantly taller (P= 0.0072) and significantly less likely to take aspirin medicines (P= 0.04).  In 
addition, subjects who had other platelet inhibitor medication history missing had significantly lower 
proportions of AAA family history and thrombosis history (P=0.0086). 
 
Table 2: Check the balance of missing observations 
Variables 
Left/Right ABI* 
P** 
Medication: Other platelet 
inhibitors 
P** 
Not missing 
(N=383/382) 
Missing 
(N=36/37) 
Not missing 
(N=337) 
Missing 
(N=82) 
Continuous variables – mean (sd) 
Age 69.2(7.6) 70.9(8.0) 0.20 69.4(7.8) 68.9(7.0) 0.61 
Height-cm 177.3(7.5) 180.9(7.7) 0.0072 177.6(7.3) 177.6(8.5) 0.98 
Weight-kg 90.8(17.0) 90.6(18.4) 0.95 89.9(15.6) 94.0(22.0) 0.11 
Left ABI - - - 0.99(0.2) 1.12(1.0) 0.29 
Right ABI - - - 0.99(0.2) 1.11(1.1) 0.32 
Binary variables – no. (%) 
Currently smokes 154(40.2) 13(36.1) 0.63 128(38.0) 39(47.6) 0.11 
Endoleak 118(30.8) 7(19.4) 0.15 105(31.2) 20(24.4) 0.23 
Family history of 
AAA 
59(15.4) 6(16.7) 0.84 60(17.8) 6(6.1) 0.0086 
Diabetes 83(21.7) 6(16.7) 0.48 74(22.0) 15(18.3) 0.47 
High cholesterol 281(73.4) 23(63.9) 0.22 248(73.6) 56(68.3) 0.34 
Thrombosis 20(5.2) 2(5.6) 0.93 22(6.5) 0(0) 0.018 
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Hypertension 302(78.9) 27(75.0) 0.59 266(78.9) 63(76.8) 0.68 
Emphysema 106(27.7) 13(36.1) 0.28 92(27.3) 27(32.9) 0.31 
Coagulopathy 5(1.3) 0(0) 0.49 5(1.5) 0(0) 0.27 
Stroke 58(15.1) 4(11.1) 0.51 47(14.0) 15(18.2) 0.32 
Cardiac disease 199(52.0) 15(7.0) 0.44 165(49.0) 49(60.0) 0.18 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: 
Beta-blockers 
252(65.8) 22(61.1) 0.57 220(65.3) 54(65.9) 0.92 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: 
Aspirin 
217(56.7) 14(39.9) 0.040 194(57.6) 37(45.1) 0.042 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: ACE 
inhibitors 
171(44.7) 12(33.3) 0.19 151(44.8) 32(39.0) 0.34 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: 
Anticoagulants 
40(10.4) 2(5.56) 0.35 31(9.2) 11(13.4) 0.25 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: 
Other platelet 
inhibitors 
22(7.1) 2(6.9) 0.96 - - - 
* Left ABI had 36 missing observations and right ABI had 37 missing observations. The missing 
observations shared 36 subjects in common (36 subjects were missing both left and right ABI values).  
Calculation in this column was based on left ABI observations. 
** P value of two sample t-test (for continuous variables) or chi-square test (for binary variables). 
 
Consequently based on the evidence above it was hard to conclude that the three variables were missing 
randomly.  On the other hand, 419 subjects might not large enough to definitively make a precise 
conclusion.  Under this circumstance, four datasets were constructed and used for further analysis: (i) one 
with all variables but incomplete subjects; (ii) one with all subjects and variables with no missing value; (iii) 
one filled with logistic regression; and (iv) one filled with multiple imputation.  
 
Logistic regression and diagnostics 
Logistic regression models were built with different variable selection techniques (no selection, forward 
selection, backward selection, and stepwise selection).  Criteria (significance level) for variable entry in 
forward and stepwise selection was set at 0.05, significance level for variable elimination in backward and 
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stepwise selection was set at 0.10.  As suggested in the section above, analysis was conducted with three 
datasets.  Part of the results including P value, OR estimate, and confidence interval of OR estimate of 
current smokes generated by logistic regression models were listed in Table 3.  An expanded result table 
containing the final model information can be found in the Appendix.  In addition, Figure 3 was generated 
to better illustrate the odds ratio estimation and confidence intervals.  From Figure 3, one can deduce that 
odds ratio for current smoking was around 0.6, although more than half (7/12) of the confidence interval 
contained the value of 1.  Of the three datasets, the one with all variables had two insignificant P values, 
the one with all subjects but partial variable list had 3 out of 4 P values significant, and the one filled with 
multiple imputation data had all P value significant. 
Table 3: Logistic regression results.  
 
Include all variables* (308 subjects) 
Variable selection 
method
** 
Currently smokes 
P OR estimate 
95% Wald 
Confidence Interval 
No selection 0.084 0.61 0.34 1.07 
Forward 0.022 0.55 0.33 0.92 
Backward 0.12 0.65 0.38 1.11 
Stepwise 0.022 0.55 0.33 0.92 
Include only no-missing variables
¶
 (419 subjects) 
Variable selection 
method
**
 
Currently smokes 
P OR estimate 
95% Wald 
Confidence Interval 
No selection 0.074 0.65 0.40 1.04 
Forward 0.019 0.59 0.38 0.92 
Backward 0.025 0.60 0.38 0.94 
Stepwise 0.019 0.59 0.38 0.92 
Data filled with multiple imputation (all variables, 419 subjects) 
Variable selection 
method
**
 
Currently smokes 
P OR estimate 
95% Wald 
Confidence Interval 
No selection 0.060 0.63 0.38 1.02 
Forward 0.063 0.64 0.40 1.03 
Backward 0.063 0.64 0.40 1.02 
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Stepwise 0.063 0.64 0.40 1.03 
*All variables = Current smoking, age, height, weight, AAA family history, diabetes, high cholesterol, 
thrombosis, emphysema, coagulopathy, stroke, cardiac disease history, beta blocker, aspirin, ACE inhibitor, 
anticoagulants, platelet inhibitor, left ABI, and right ABI.  
**Significance criteria: SLENTRY=0.05, SLSTAY=0.10. 
¶
All variables except left ABI, right ABI, and platelet inhibitor. 
 
 
Figure 3: OR estimate and confidence interval by logistic regressions.  Left four lines stand for OR 
confidence intervals calculated with data including all variables.  Four lines in the middle stand for OR 
confidence intervals calculated with data including all subjects.  And right four lines stand for OR 
confidence intervals calculated with data filled by multiple imputation.  
 
For all the logistic regression models, the Hosmer and Lemeshow goodness-of-fit test was used to assess the 
overall fitness of the models.  Predicted probability diagnostics plot, leverage diagnostics plot, and 
influence on the model fit and parameter estimates plot were used to identify the outliers and 
high-influenced plots.  Results of goodness-of-fit test can be found in Table 4.  All the logistic models 
listed in the table had P value greater than 0.05, indicating that none of the model fit was significantly bad.  
The predicated probability diagnostics plots, leverage diagnostics plots, and influence on the model fit and 
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parameter estimation plots were provided in the Appendix. 
 
Table 4: Logistic regression model diagnostic (Hosmer and Lemeshow Goodness-of-fit test) 
Model selection 
method 
Model Detail 
Hosmer and Lemeshow Goodness-of-fit 
test 
Chi-square DF Pr>ChiSq 
Include all variables* (308 subjects) 
No selection 
Logit(endoleak) = Current Smokes + All 
variables 
13.31 8 0.10 
Forward 
Logit(endoleak) = Current Smokes + Beta 
Blocker 
0.076 2 0.96 
Backward 
Logit(endoleak) = Current Smokes + Age + 
Aspirin + Anticoag + PlateletInhib 
12.07 8 0.14 
Stepwise 
Logit(endoleak) = Current Smokes + Beta 
Blocker 
0.076 2 0.96 
Include only no-missing variables
¶
 (419 subjects) 
No selection 
Logit(endoleak) = Current Smokes + All 
variables 
9.48 8 0.30 
Forward Logit(endoleak) = Current Smokes - - - 
Backward 
Logit(endoleak) = Current Smokes + 
Diabetes + Anticoag 
0.22 3 0.97 
Stepwise Logit(endoleak) = Current Smokes - - - 
Data filled with multiple imputation (all variables, 419 subjects) 
No selection 
Logit(endoleak) = Current Smokes + All 
variables 
12.14 8 0.15 
Forward 
Logit(endoleak) = Current Smokes + Age + 
Diabetes + Right_ABI + PlateletInhib 
6.62 8 0.58 
Backward 
Logit(endoleak) = Current Smokes + Age + 
Family History + Diabetes + Anticoagulants 
+ Right_ABI + PlateletInhib 
9.90 8 0.27 
Stepwise 
Logit(endoleak) = Current Smokes + Age + 
Diabetes + Right_ABI + PlateletInhib 
6.62 8 0.58 
 
Propensity score analysis and diagnostics 
The first step of implementing propensity score methodology was to generate propensity scores.  In the 
logistic regression models that calculated propensity score, all the available baseline effects were included 
and variable lists varied by data set.  Figure 4 showed the histograms of propensity scores by smoking 
status in different datasets, one could see that propensity scores in all data sets had significantly different 
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distributions (P values of two sample t-test were less than .0001 in all cases).  Although the distributions of 
propensity score were different, the ranges of distributions for smokers and non-smokers almost overlapped.  
In this situation, matching using propensity score can allow for reasonable matched pairs and can also 
improve the results by matching cases to similar controls.  In addition, covariate adjustment and 
stratification with propensity score may also worked well because of the comparability of case and control 
groups.  Therefore, it appeared that the propensity score method addressed the problem well. 
 
Include all variables (308 subjects)     Include only no-missing variables (419 subjects) 
 
            Data filled by multiple imputation (all variables, all subjects) 
       
Figure 4: Histograms of propensity score by smoking status for data set including all variables (top left), 
data set including all subjects and only no-missing variables (top right), data set filled by multiple 
imputation (bottom).  X-axis was estimated probability (propensity score estimate).  Y-axis is frequency.  
Yellow dotted lines were normal approximation based on data.  P values of two sample t-test for all three 
situations are less than .0001.  
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The results by multiple propensity score methods were presented in Table 5.  First, it was noticed that 
the numbers of matched pairs were pretty satisfactory, especially in the second and third data sets. The 
first dataset included all variables but only 308 subjects (118 current smokers and 190 current 
non-smokers), which was less than the second and third data sets, and thus less matched pairs.  For the 
second dataset, no less than 130 pairs were matched, that was 68 percent of all cases or 80 percent of the 
all the controls.  Second, from the perspective of results, all confidence intervals of odds ratios of current 
smoking included 1 in the range except in three cases.  To understand the results better, the results of 
odds ratio estimation and confidence intervals were presented in Figure 5.  Compared with Figure 3, the 
odds ratio estimation demonstrated in Figure 5 had a larger range (0.47 to 0.77).  In addition, larger 
proportions of confidence intervals included 1 in Figure 5 compared to in Figure 3.  To conclude, more 
evidence pointed towards the suggestion that smoking was not significantly related with endoleak 
occurrence after propensity score methods were used. 
 
Table 5: Propensity score models results.  
Include all variables* (308 subjects) 
Methods
 
Currently smokes 
Matched 
pairs 
P OR estimate 
95% Wald 
Confidence Interval 
Covariate adjustment - 0.090 0.62 0.36 1.08 
Stratification - 0.092 0.62 0.36 1.08 
Greedy 1 to 1 0.1 logit ps.sd matching 95 0.062 0.53 0.27 1.03 
Greedy 1 to 1 0.2 logit ps.sd matching 97 0.040 0.49 0.25 0.97 
Greedy 1 to 1 0.5 logit ps.sd matching 101 0.030 0.47 0.24 0.93 
Mahalanobis matching 99 0.25 0.69 0.37 1.30 
Include only no-missing variables
¶
 (419 subjects) 
Methods 
 Currently smokes 
Matched 
pairs 
P OR estimate 
95% Wald 
Confidence Interval 
Covariate adjustment - 0.079 0.66 0.41 1.05 
Stratification - 0.058 0.63 0.39 1.02 
Greedy 1 to 1 0.1 logit ps.sd matching 130 0.30 0.72 0.38 1.34 
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Greedy 1 to 1 0.2 logit ps.sd matching 133 0.50 0.82 0.46 1.45 
Greedy 1 to 1 0.5 logit ps.sd matching 141 0.36 0.77 0.44 1.35 
Mahalanobis matching 136 0.19 0.70 0.42 1.19 
Data filled with multiple imputation (all variables, 419 subjects) 
Methods 
 Currently smokes 
Matched 
pairs 
P OR estimate 
95% Wald 
Confidence Interval 
Covariate adjustment - 0.083 0.66 0.41 1.06 
Stratification - 0.076 0.65 0.41 1.05 
Greedy 1 to 1 0.1 logit ps.sd matching 129 0.091 0.59 0.32 1.09 
Greedy 1 to 1 0.2 logit ps.sd matching 131 0.11 0.63 0.35 1.12 
Greedy 1 to 1 0.5 logit ps.sd matching 141 0.04 0.55 0.31 0.98 
Mahalanobis matching 99 0.26 0.70 0.37 1.31 
*All variables = Currently smokes, age, height, weight, family history, diabetes, high cholesterol, 
thrombosis, emphysema, coagulopathy, stroke, cardiac disease history, beta blocker, aspirin, ACE inhibitor, 
anticoagulants, platelet inhibitor, left ABI, and right ABI.  
¶
All variables except left ABI, right ABI, and platelet inhibitor. 
 
 
Figure 5: OR estimate and confidence interval by propensity score methods.  Left six lines stand for OR 
confidence intervals calculated with data including all variables.  Six lines in the middle stand for OR 
confidence intervals calculated with data including all subjects.  And right six lines stand for OR 
confidence intervals calculated with data filled by multiple imputation.  
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To make sure that propensity score matching did make the case and control groups more balanced,   
standardized differences of each variable before and after matching were checked in all models.  
Table 6 listed the standardized differences of all variables before and after matching in greedy 1:1 
matching with 0.1 logit propensity score standard deviation using data including all variables.  
Standardized difference equal to 0.1 usually indicated a big unbalance between the two groups.  
Before matching, age (sdd=0.51), weight (sdd=0.28), right ABI (sdd=0.11), stroke (sdd=0.12), and 
medication-beta blocker (sdd=0.15) were all considered unbalanced variables.  Age was the most 
unbalanced variable and had standardized difference 0.51 which demonstrated a substantial 
unbalance.  After matching, almost all variables were balanced except for right ABI (sdd=0.15) and 
cardiac disease (sdd=0.15), which were just mildly unbalanced.  And in the following analysis, right 
ABI and cardiac disease were added to the model to ensure the minimum bias caused by unbalanced 
variables. 
 
Table 6: Check balance before and after matching with propensity score: standardized difference. 
(Use Greedy 1 to 1 0.1 logit ps.sd matching applying to data including all variables as an example) 
Variables 
Current smokers vs. Current non-smokers 
By smoking status By endoleak occurrence 
Continuous variables 
Age-yr 0.51 0.076 
Height-cm 0.031 0.023 
Weight-kg 0.28 0.023 
Left ABI 0.084 0.002 
Right ABI 0.11 0.15 
Binary variables 
Family history of abdominal 
aortic aneurysm 
0.083 0.056 
Diabetes 0.068 0.025 
High cholesterol 0.008 0.048 
Thrombosis 0.074 0.000 
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Hypertension 0.029 0.029 
Emphysema 0.006 0.071 
Coagulopathy 0.009 0.085 
Stroke 0.12 0.056 
Cardiac disease 0.069 0.15 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: Beta-blockers 0.15 0.045 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: Aspirin 0.059 0.000 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: ACE 
inhibitors 
0.028 0.021 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: 
Anticoagulants 
0.053 0.076 
𝐌𝐞𝐝𝐢𝐜𝐚𝐭𝐢𝐨𝐧¶: Other platelet 
inhibitors 
0.023 0.039 
 
Because of the differences between logistic regression results (Table 3) and propensity score results 
(Table 5), one would question whether the data matched by propensity score would still generate the same 
results if logistic regression models were applied.  Following this hypothesis, logistic regressions were 
used in the propensity-score-matching to generate datasets and the results.  The results presented in Table 
7 indicated that more results were significant in some datasets, especially the data sets including all 
variables.  However, in datasets including all subjects and datasets filled with multiple imputations, all 
the results were not significant. 
 
Table 7: Logistic regression with propensity-score-matching generated datasets 
Include all variables* 
Using dataset generated by
 
 Currently smokes 
Method Matched 
Pair 
P OR estimate 
95% Wald 
Confidence Interval 
Greedy 1 to 1 0.1 logit ps.sd matching 
No selection 95 0.032 0.46 0.23 0.94 
Forward 95 0.049 0.52 0.27 1.00 
Backward 95 0.053 0.52 0.27 1.01 
Stepwise 95 0.049 0.52 0.27 1.00 
Greedy 1 to 1 0.2 logit ps.sd matching 
No selection 97 0.028 0.46 0.23 0.92 
Forward 97 0.048 0.51 0.26 1.00 
Backward 97 0.053 0.52 0.26 1.01 
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Stepwise 97 0.048 0.51 0.26 1.00 
Greedy 1 to 1 0.5 logit ps.sd matching 
No selection 101 0.023 0.49 0.22 0.90 
Forward 101 0.041 0.50 0.26 0.97 
Backward 101 0.041 0.50 0.26 0.97 
Stepwise 101 0.041 0.50 0.26 0.97 
Mahalanobis matching with 0.2 logit 
ps.sd 
No selection 99 0.28 0.69 0.35 1.36 
Forward 99 0.34 0.73 0.39 1.39 
Backward 99 0.38 0.75 0.39 1.43 
Stepwise 99 0.34 0.73 0.39 1.39 
Include only no-missing variables
¶
 
Using dataset generated by 
  Currently smokes 
Method Matched 
pairs 
P OR estimate 
95% Wald 
Confidence Interval 
Greedy 1 to 1 0.1 logit ps.sd matching 
No selection 130 0.20 0.69 0.39 1.22 
Forward 130 0.17 0.68 0.39 1.19 
Backward 130 0.15 0.66 0.38 1.16 
Stepwise 130 0.17 0.68 0.39 1.19 
Greedy 1 to 1 0.2 logit ps.sd matching 
No selection 133 0.43 0.80 0.46 1.39 
Forward 133 0.38 0.79 0.46 1.34 
Backward 133 0.39 0.79 0.46 1.36 
Stepwise 133 0.38 0.79 0.46 1.34 
Greedy 1 to 1 0.5 logit ps.sd matching 
No selection 141 0.20 0.70 0.41 1.21 
Forward 141 0.16 0.69 0.40 1.16 
Backward 141 0.16 0.69 0.40 1.16 
Stepwise 141 0.16 0.69 0.40 1.16 
Mahalanobis matching with 0.2 logit 
ps.sd 
No selection 136 0.14 0.65 0.37 1.15 
Forward 136 0.18 0.68 0.39 1.19 
Backward 136 0.18 0.68 0.39 1.19 
Stepwise 136 0.18 0.68 0.39 1.19 
Data filled with multiple imputation (all variables, all subjects) 
Using dataset generated by 
  Currently smokes 
Method Matched 
pairs 
P OR estimate 
95% Wald 
Confidence Interval 
Greedy 1 to 1 0.1 logit ps.sd matching 
No selection 128 0.10 0.61 0.34 1.10 
Forward 128 0.15 0.66 0.38 1.16 
Backward 128 0.15 0.66 0.38 1.16 
Stepwise 128 0.15 0.66 0.38 1.16 
Greedy 1 to 1 0.2 logit ps.sd matching 
No selection 131 0.11 0.62 0.35 1.11 
Forward 131 0.12 0.64 0.37 1.12 
Backward 131 0.14 0.66 0.38 1.15 
Stepwise 131 0.12 0.64 0.37 1.12 
Greedy 1 to 1 0.5 logit ps.sd matching No selection 141 0.078 0.61 0.35 1.06 
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Forward 141 0.098 0.64 0.37 1.09 
Backward 141 0.098 0.64 0.37 1.09 
Stepwise 141 0.098 0.64 0.37 1.09 
Mahalanobis matching with 0.2 logit 
ps.sd 
No selection 99 0.37 0.73 0.37 1.44 
Forward 99 0.44 0.77 0.41 1.48 
Backward 99 0.46 0.78 0.41 1.50 
Stepwise 99 0.44 0.77 0.41 1.48 
 
Simulation 
A total of one hundred datasets had been generated by multiple imputation and the following simulation 
process.  Then, these data sets were analyzed by logistic regression and propensity score method as 
described above.  The results were collected and summarized in Tables 8 and 9.  First, the p value 
estimations and OR estimations in the two tables were stable over different methods, except for the p 
value estimation of propensity score method with mahalanobis matching.  All the means of odds ratio 
estimations of developing endoleaks in smoking subjects versus non-smoking subjects remained 
between 0.75 and 0.80. 
 
Further, neither the results of p value nor the results of odds ratio were significant.  All the confidence 
intervals of P values contained 0.05 and all the confidence intervals of odds ratio included 1.  Therefore, 
we failed to conclude that smoking was a significant factor.   Last but not the least, although 1 was 
included in the confidence intervals of odds ratio estimates, all the odds ratio estimations were smaller 
than 1, which provided evidence to support that smoking had a protective effect on endoleak incidence.   
 
In summary, simulations indicated that smokers may have lower risk of developing endoleak compared 
with non-smokers, although this effect was not significant in this analysis.  Larger sample size might be 
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necessary for further confirming this finding. 
 
Table 8: Simulation: logistics regression 
Variable selection 
method
 
Currently smokes 
P OR 
Mean 
95% Confidence 
Interval 
Estimate 
mean 
95% Confidence 
Interval 
95% Prediction 
Interval 
No selection 0.32 (0.004, 0.96) 0.77 (0.5, 1.16) (0.32, 1.86) 
Forward 0.28 (0.002, 0.85) 0.77 (0.51, 1.18) (0.34, 1.80) 
Backward 0.30 (0.003, 0.90) 0.78 (0.52, 1.18) (0.33, 1.80) 
Stepwise 0.29 (0.002, 0.85) 0.77 (0.51, 1.17) (0.34, 1.80) 
 
Table 9: Simulation: propensity score 
Methods
 
Currently smokes 
P OR 
Mean 
95% 
Confidence 
Interval 
Estimate 
mean 
95% Confidence 
Interval 
95% Prediction 
Interval 
Covariate adjustment 0.32 (0.005, 0.91) 0.80 (0.52, 1.15) (0.33, 1.81) 
Stratification 0.33 (0.005, 0.90) 0.79 (0.53, 1.15) (0.34, 1.80) 
Greedy 1 to 1 0.1 logit ps.sd matching 0.32 (0.003, 0.88) 0.76 (0.44, 1.20) (0.25, 2.0) 
Greedy 1 to 1 0.2 logit ps.sd matching 0.31 (0.003, 0.91) 0.78 (0.46, 1.23) (0.26, 2.04) 
Greedy 1 to 1 0.5 logit ps.sd matching 0.30 (0.0036, 0.93) 0.77 (0.45, 1.20) (0.26, 2.02) 
Mahalanobis matching 0.09 (0, 0.64) 0.75 (0.46, 1.13) (0.39, 1.42) 
 
 
DISCUSSION 
Several studies have investigated the risk factors for endoleak in recent years and had made significant 
progress
11,15-18
.  Although not every studies included smoking as a potential risk factor, all studies that 
had included smoking in the analysis found that the proportions of previous or current smokers who had 
developed an endoleak were smaller
11,15-17
.  The methods used in these studies were either multivariate 
(logistic) regression techniques or chi-square tests.  In order to address the finding that smokers may 
have lower incidence of endoleaks, a few explanations were given in the above studies: Buth et al. 
suggested that changes in the coagulation profile of the blood caused by smoking may lead to a tendency 
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of quick occlusion of small vessels, which caused the spontaneous heal of endoleaks
15,17
.  The analysis 
described in this project confirmed the conclusion that the odds of developing endoleak for current 
smokers were smaller than the odds of developing endoleak for current non-smokers even if the 
confidence intervals of odds ratio were not statistically significant.  Compared to the previous studies, 
this study used more sophisticated statistical approaches/analytical techniques and utilized more 
relavantcovariates in the analysis. 
 
The propensity score method was chosen to analyze the data due to its ability to balance the dissimilar 
characteristics between case and control groups.  In reality, smokers and non-smokers usually had 
systematically different characteristics, such as age and cardiac disease history.  As in the case of the VA 
trial’s endoleak dataset, it had been discovered in the preliminary analysis that current non-smokers were 
older and heavier than current smokers, which might cause bias to the following analysis.  After 
matching or stratifying by propensity score, the difference between characteristics of smokers and 
non-smokers became small.  The second positive aspect about propensity score was that all suspected 
covariates can be contained in the model, which was in contrast with the parsimonious variable selection 
in logistic regressions.  Including more variables in the model was able to further minimize the bias and 
improve fit of the model, and the VA endoleak data set included more than 20 variables.  Lastly, but not 
the least, propensity score method fitted the scenario of the question very well.  Hernan and Taubman 
argued that it was important to have a well-defined intervention when raising questions about the 
investigation of causal relationships
26
.  In the current study, the main interest was the presence or not of a 
causal relationship between smoking and risk of endoleak development.  A randomized trial with smoking 
cessation as intervention to reduce the incidence of endoleaks in this patient population may be difficult, 
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although not impossible, to implement.  Therefore, all subjects with a smoking history were included and 
propensity score was used to itimate the endoleak study with an ideal randomized experiment trial. 
 
However, propensity score method had its own limitations.  First, as suggested by Rubin and Rosenbaum, 
propensity score can only balance the observed covariates
19
.  If the study was biased by unmeasured or 
hidden covariates, the propensity-score-generated results would not be corrected.  Second, not all 
observations were used in the analysis.  One might observe the differences between the total number of 
subjects in the data set and the number of subjects left after matching.  This partial-use of information may 
also cause bias. 
 
The pros and cons of logistic regression and propensity score method had been discussed for a few years, and 
no consensus had been reached.  Two recent literature review studies concluded that treatment effects 
estimated by propensity score methods and regression techniques were similar to each other, while another 
simulation study found that propensity score method provided systematically better estimation for treatment 
effect compared with logistics regression
27,28
.  In the current study, the results of propensity score and 
logistic regression were similar.  Although they both generated odds ratio estimations less than 1, one may 
observe that propensity score had less significant p value estimations and wider confidence interval for odds 
ratio.  Two reasons may provide possible explanations: (a)   The sample size was reduced after matching 
by propensity score and such reduction increased the estimated standard deviation of odds ratio estimations 
and widened the confidence intervals; (b) The propensity score indeed decreased the bias and made the 
estimations shift towards null effects.  Larger sample sizes were needed to decide which one(s) was the 
reason(s) for the differences. 
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In addition to the potential drawbacks of the propensity score methodology, this study had other limitations. 
For instance, all the subjects in the study were male.  This may restrict the finding to only male patients. 
Another limitation was the missing data.  Although multiple imputation techniques and simulation were 
used to decrease the impact of the missing data, the missing pattern was impossible to detect through the 
existing data and negative influence may still exist. 
 
Smoking cessation had almost always been found as a beneficial intervention towards improving cardiac 
health, especially for patients after cardiac surgeries
31-34
.  It has been reported that patients who had quitted 
smoking experienced a significant reduction in sudden cardiac death
27 
and had a significant decrease in 
mortality after myocardial infarction
30
.  However, the pros and cons of smoking for patients after 
endovascular repair needed further examination and discussion. 
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Appendix 1: Logistic regression (with whole model column).  
Include all variables* (308 subjects) 
Variable selection 
method
** 
Currently smokes 
Whole model 
P OR estimate 
95% Wald 
Confidence Interval 
No selection 0.084 0.61 0.34 1.07 Logit(endoleak) = Current Smokes + All variables 
Forward 0.022 0.55 0.33 0.92 Logit(endoleak) = Current Smokes + Beta Blocker 
Backward 0.12 0.65 0.38 1.11 
Logit(endoleak) = Current Smokes + Age + 
Aspirin + Anticoag + PlateletInhib 
Stepwise 0.022 0.55 0.33 0.92 Logit(endoleak) = Current Smokes + Beta Blocker 
Include only no-missing variables
¶
 (419 subjects) 
Variable selection 
method** 
Currently smokes 
Whole model 
P OR estimate 
95% Wald 
Confidence Interval 
No selection 0.074 0.65 0.40 1.04 Logit(endoleak) = Current Smokes + All variables 
Forward 0.019 0.59 0.38 0.92 Logit(endoleak) = Current Smokes 
Backward 0.025 0.60 0.38 0.94 
Logit(endoleak) = Current Smokes + Diabetes + 
Anticoag 
Stepwise 0.019 0.59 0.38 0.92 Logit(endoleak) = Current Smokes 
Data filled with multiple imputation (all variables, 419 subjects) 
Variable selection 
method** 
Currently smokes 
Whole model 
P OR estimate 
95% Wald 
Confidence Interval 
No selection 0.0601 0.63 0.38 1.02 Logit(endoleak) = Current Smokes + All variables 
Forward 0.0632 0.64 0.40 1.03 
Logit(endoleak) = Current Smokes + Age + 
Diabetes + Right_ABI + PlateletInhib 
Backward 0.063 0.64 0.40 1.02 
Logit(endoleak) = Current Smokes + Age + 
Family History + Diabetes + Anticoagulants + 
Right_ABI + PlateletInhib 
Stepwise 0.063 0.64 0.40 1.03 
Logit(endoleak) = Current Smokes + Age + 
Diabetes + Right_ABI + PlateletInhib 
*All variables = Currently smokes, age, height, weight, family history, diabetes, high cholesterol, 
thrombosis, emphysema, coagulopathy, stroke, cardiac disease history, beta blocker, aspirin, ACE inhibitor, 
anticoagulants, platelet inhibitor, left ABI, and right ABI.  
**Significance criteria: SLENTRY=0.05, SLSTAY=0.10. 
¶
All variables except left ABI, right ABI, and platelet inhibitor. 
 
